SEOM clinical guidelines for the treatment of head and neck cancer (2017)
Resumen: Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2013 publication, Spanish Society of Medical Oncology (SEOM) presents an update of HNC diagnosis and treatment guideline. The eighth edition of TNM classification, published in January 2017, introduces important changes for p16-positive oropharyngeal tumours, for lip and oral cavity cancer and for N3 category. In addition, there are new data about induction chemotherapy and the role of immunotherapy in HNC.
Idioma: Inglés
DOI: 10.1007/s12094-017-1776-1
Año: 2017
Publicado en: Clinical and Translational Oncology 20 (2017), 75 - 83
ISSN: 1699-048X

Factor impacto JCR: 2.392 (2017)
Categ. JCR: ONCOLOGY rank: 156 / 223 = 0.7 (2017) - Q3 - T3
Factor impacto SCIMAGO: 0.819 - Medicine (miscellaneous) (Q2) - Oncology (Q2) - Cancer Research (Q3)

Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2020-06-09-13:22:16)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2018-01-12, last modified 2020-06-09


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)